Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2569–2592 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Major Depressive Disorder With Suicidal Ideation With Intent
Interventions: MIJ821 Intravenous Injection, Placebo Intravenous Injection; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 6
States / cities: Birmingham, Alabama • Farmington, Connecticut • Oakland Park, Florida + 3 more

Conditions: Heroin Dependence, Opioid-Related Disorders
Interventions: Hydromorphone; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sacroiliac Joint Dysfunction
Interventions: SImmetry; Device
Lead sponsor: Surgalign Spine Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 22
States / cities: Phoenix, Arizona • Newport Beach, California • Oakland, California + 19 more

Conditions: Stroke, Vascular Dementia, Memory Deficits
Interventions: Donepezil and self-generated memory training, Donepezil and experimenter-administered memory training; Drug
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2021
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Myelodysplastic Syndrome, MDS
Interventions: pracinostat, Azacitidine, Decitabine; Drug
Lead sponsor: Helsinn Healthcare SA; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 21
States / cities: Mobile, Alabama • Duarte, California • Los Angeles, California + 17 more

Conditions: Employee Health and Well-being
Interventions: Workplace Wellness Program, Biometric Screening/HRA - No Compensation, Biometric Screening/HRA - Moderate Compensation, Biometric Screening/HRA - High Compensation, Wellness Activities - Low Compensation, Wellness Activities - High Compensation; Behavioral
Lead sponsor: National Bureau of Economic Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 4,834 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: PTSD, Chronic Musculoskeletal Pain
Interventions: Mission Reconnect; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Tampa, Florida • Ann Arbor, Michigan • Seattle, Washington

Conditions: Healthy Controls, Alcohol Use Disorder
Interventions: Placebo, Oxytocin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 45 Years
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Dry Eye
Interventions: HL036 ophthalmic solution, Placebo vehicle solution; Biological · Other
Lead sponsor: HanAll BioPharma Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Lewiston, Maine • Andover, Massachusetts

Conditions: Urinary Incontinence
Interventions: Academic Detailing, Electronic Clinical Decision Support, APP Co-management, Electronic Referral; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: La Jolla, California • Los Angeles, California • Torrance, California

Conditions: Neuromyelitis Optica Spectrum Disorder, NMOSD
Interventions: Satralizumab 120 mg; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Abdominal Pain
Interventions: Placebo, HBB 20 mg; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 19
States / cities: Westlake Village, California • Hollywood, Florida • Jupiter, Florida + 14 more

Conditions: Pregnancy, Binge Eating
Interventions: Mindful Eating Self-Help Program, Mindful Eating Smartphone Application (Am I Hungry? Virtual Coach); Behavioral
Lead sponsor: University of North Carolina, Charlotte; Other
Eligibility: 18 Years to 40 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Renal Cell Carcinoma
Interventions: Erlotinib hydrochloride, Sirolimus; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Mobility Limitation, Physical Disability
Interventions: HIFT for people with MRD; Other
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Hypertension, Health Behavior, Healthcare Patient Acceptance, Patient Engagement, Adherence, Patient
Interventions: Remote Patient Monitoring, Self-monitoring of hypertension-related factors, Immediate financial incentives, Delayed financial incentives; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Bastrop, Louisiana • Shreveport, Louisiana

Conditions: Depression, Stress, Psychological, Self Efficacy, Loneliness, Social Isolation, Health Care Utilization, Dementia, Dementia Alzheimers, Dementia of Alzheimer Type, Dementia, Vascular, Dementia Frontal, Dementia, Lewy Body, Dementia, Mixed, Dementia in Parkinsons Disease, Dementia, HIV, Dementia Frontotemporal, Dementia, Multi-Infarct
Interventions: Building Better Caregivers Workshop, Attention Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 418 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Renal Cancer
Interventions: BEZ235; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy
Interventions: Esketamine; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 20 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cypress, California

Conditions: Insulin Treated Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 1
Interventions: Control:Diabetes mobile app; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Homelessness, Substance Abuse Disorders, Mental Disorders
Interventions: Intensive Addiction/Housing Case Management, Housing Support Group; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alcohol Use Disorder
Interventions: DynamiCare Rewards; Behavioral
Lead sponsor: DynamiCare Health; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Centerville, Massachusetts • Falmouth, Massachusetts

Conditions: Spinal Cord Injuries, Type 2 Diabetes
Interventions: Semaglutide Injectable Product, Placebo; Drug · Other
Lead sponsor: Marzieh Salehi; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: San Antonio, Texas

Conditions: Parkinson Disease
Interventions: Occupational therapy intervention group, Disease management education group; Behavioral
Lead sponsor: San Jose State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: San Jose, California • New York, New York

Search by objective public record fields.

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals

Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System

Aricept to Improve Functional Tasks in Vascular Dementia

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA

Illinois Workplace Wellness Study

Mission Reconnect-Veterans and Their Partners to Manage Pain and PTSD (MR)

Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II

A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes

A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis

Empowering Mindfulness, Body Respect, and Compassionate Eating Among Women Who Binge Eat During Pregnancy

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

HIFT for People With Mobility-Related Disabilities

Building Engagement Using Financial Incentives Trial - Hypertension

Rural Dementia Caregiver Project

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects

Control:Diabetes Pilot Study I

Addiction Housing Case Management for Homeless Veterans

Contingency Management for Alcohol Use Disorder

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease